754 results on '"Dunlop, Adrian"'
Search Results
2. How I manage severe bacterial infections in people who inject drugs
3. Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs
4. 96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial
5. Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs
6. Participant experiences in a pilot study for methamphetamine withdrawal treatment: Implications for retention
7. Health-Related Quality of Life of People Who Inject Drugs: The Enhancing Treatment of Hepatitis C in Opioid Substitution Settings Engage Study
8. Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal.
9. Investigating associations between methamphetamine use, mental health and risky sexual behaviours amongst Aboriginal and Torres Strait Islander peoples
10. Health and correctional staff acceptability of depot buprenorphine in NSW prisons
11. Differential effectiveness of a practice change intervention to improve antenatal care addressing alcohol consumption during pregnancy: Exploratory subgroup analyses within a randomised stepped-wedge controlled trial
12. Pilot study with randomised control of dual site theta burst transcranial magnetic stimulation (TMS) for methamphetamine use disorder: a protocol for the TARTAN study
13. Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibility and safety trial
14. Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage Study
15. A pilot randomised controlled trial of abrupt versus gradual smoking cessation in combination with vaporised nicotine products for people receiving alcohol and other drug treatment
16. Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study
17. Mood, sleep and pain comorbidity outcomes in cannabis dependent patients: Findings from a nabiximols versus placebo randomised controlled trial
18. Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder
19. Using mixed methods to establish tobacco treatment acceptability from the perspective of clients and clinicians of antenatal substance use services
20. Cost, cost-consequence and cost-effectiveness evaluation of a practice change intervention to increase routine provision of antenatal care addressing maternal alcohol consumption
21. Effectiveness of a practice change intervention in reducing alcohol consumption in pregnant women attending public maternity services
22. Practice change intervention to improve antenatal care addressing alcohol consumption during pregnancy: a randomised stepped-wedge controlled trial
23. Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence
24. A qualitative study of using nicotine products for smoking cessation after discharge from residential drug and alcohol treatment in Australia
25. A web-based application for reducing methamphetamine use amongst Aboriginal and Torres Strait Islander people: A wait-list control randomised trial. (Preprint)
26. We Can Do This: A web-based therapeutic program for reducing methamphetamine use -amongst Aboriginal and Torres Strait Islander people: Findings from a wait-list control, randomised trial (Preprint)
27. The uptake of long‐acting depot buprenorphine for treating opioid dependence in Australia, 2019–2022: longitudinal sales data analysis
28. Tracing the affordances of long-acting injectable depot buprenorphine: A qualitative study of patients’ experiences in Australia
29. Needle and syringe sharing among people who have recently injected drugs in Australia: The ETHOS Engage Study.
30. Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trial
31. Psychological treatment for methamphetamine use and associated psychiatric symptom outcomes: A systematic review
32. The provision of preventive care for modifiable health risk behaviours by clinicians within substance use treatment settings: A systematic review
33. Measuring Objective and Subjective Sleep during Lisdexamfetamine Treatment of Acute Methamphetamine Withdrawal: A Feasibility Study
34. Understanding the research capacity of alcohol and other drugs services in New South Wales, Australia
35. The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients
36. Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy
37. Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study
38. Is post-traumatic stress disorder a risk factor for development of opioid use disorder among individuals with chronic non-cancer pain? A systematic review.
39. Tobacco treatment incorporating contingency management, nicotine replacement therapy, and behavioral counseling for pregnant women who use substances: a feasibility trial
40. OBJECTIVE AND SUBJECTIVE SLEEP DURING LISDEXAMFETAMINE TREATMENT OF ACUTE METHAMPHETAMINE WITHDRAWAL: NEW MEASUREMENT PARADIGM
41. Effect of electronic screening and brief intervention on hazardous or harmful drinking among adults in the hospital outpatient setting: A randomized, double-blind, controlled trial
42. Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial
43. Effect of electronic brief intervention on uptake of specialty treatment in hospital outpatients with likely alcohol dependence: Pilot randomized trial and qualitative interviews
44. Escalating patterns of emergency health care prior to first admission with amphetamine psychosis: A window of opportunity?
45. Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study
46. Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study
47. Smoking cessation care provision in Australian alcohol and other drug treatment services: A cross-sectional survey of staff self-reported practices
48. Addiction stigma and the biopolitics of liberal modernity: A qualitative analysis
49. Effectiveness and cost-effectiveness of unsupervised buprenorphine-naloxone for the treatment of heroin dependence in a randomized waitlist controlled trial
50. Protocol for an economic evaluation and budget impact assessment of a randomised, stepped-wedge controlled trial for practice change support to increase routine provision of antenatal care for maternal alcohol consumption
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.